Articles From: Neurocrine Biosciences Announces Granting of Orphan Drug Status for NBI-77860 in Congenital Adrenal Hyperplasia to Orvana Continues to Deliver Results in the First Quarter 2015 and Reaffirms 2015 Production Guidance


2015/1/16
AT&T Donates $65,000 to the Boys & Girls Club of Fresno FRESNO, Calif.
Sign-up for New AT&T Store In Fresno Features An Innovative Design That Mirrors Customers' Mobile Lifestyles investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0988015001&sourceType=1 http://media3.marketwire.com/docs/nexc_purpose_logo_200.jpg TORONTO, ONTARIO --
Sign-up for NexC Partners Corp. Declares 2014 Capital Gains Dividends investment picks
2015/1/16
By Kjetil Malkenes Hovland OSLO--The finance minister of Norway, Western Europe's biggest oil producer, said on Friday that she would sanction extra fiscal stimulus if the economic outlook were to worsen further but for now her budget plan for 2015 still holds despite the rapid drop in crude prices.
Sign-up for Norway Sticks to Budget Plan Despite Oil-Price Slump investment picks
2015/1/16
By Juhana Rossi And Kjetil Malkenes Hovland OSLO--Norwegian telecommunications operator Telenor ASA said Friday it is seeking an explanation from VimpelCom Ltd., an Amsterdam-based telecoms operator in which Telenor is a minority owner, about what Telenor described as bribery allegations linked to a probe involving VimpelCom's business in Uzbekistan.
Sign-up for Norway's Telenor Seeks Explanation From VimpelCom on New Allegations investment picks
2015/1/16
This notice relates to a proposed voluntary dismissal of a shareholder derivative action and is being given pursuant to an order of The U.S. District Court for the Western District of Oklahoma.
Sign-up for Notice of Proposed Voluntary Dismissal of Derivative Action investment picks
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of NPS Pharmaceuticals, Inc. NEW YORK , Jan.
Sign-up for NPS PHARMACEUTICALS, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of NPS Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Shire Plc - NPSP investment picks
2015/1/16
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of NPS Pharmaceuticals Inc. (NasdaqGS:NPSP) (“NPSP”) in connection with the sale of the Company to Shire plc.
Sign-up for NPSP INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. in Connection with the Fairness of the Sale of the Company to Shire plc investment picks
Levi & Korsinsky is investigating the Board of Directors of NetScout Systems, Inc. (“NetScout” or “the Company”) (NasdaqGS: NTCT) for possible breaches of fiduciary duty and other violations of state law in connection with the Company’s purchase of Danaher Corp.’s (NYSE: DHR) Communications Business, including Tektronix Communications, Arbor Networks, and parts of Fluke Networks.
Sign-up for NTCT INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation of the Board of Directors of NetScout Systems, Inc. Concerning Purchase of Danaher Assets -- NTCT investment picks
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, today announced that the Board of Trustees of the Nuveen Preferred and Income Term Fund ( NYSE: JPI ) has approved a change to the fund’s investment policies.
Sign-up for Nuveen Preferred and Income Term Fund Announces Policy Change investment picks
2015/1/16
EINDHOVEN, Netherlands, Jan.
Sign-up for NXP Semiconductors Announces Conference Call to Review Fourth Quarter and Full-Year 2014 Financial Results investment picks
2015/1/16
By Carol E.
Sign-up for Obama Pledges U.S. Support for Europe's Terror Fight investment picks
OCI Resources LP (the "Partnership") (NYSE: OCIR) announced today the approval, on January 15, 2015, of an increase to its quarterly distribution by the board of directors of its general partner.
Sign-up for OCI Resources LP Increases Quarterly Cash Distribution investment picks
2015/1/16
By Russ Britt, MarketWatch Tavenner to leave as head of Centers for Medicare and Medicaid Marilyn Tavenner, who oversaw the Centers for Medicare and Medicaid during one of the most tumultuous periods in its history, is stepping down as the agency's administrator, the agency said Friday.
Sign-up for Official who oversaw rocky Obamacare rollout is stepping down investment picks
2015/1/16
LONDON--Oil futures edged up on Friday as the International Energy Agency said a price recovery might be in sight.
Sign-up for Oil Edges Higher on IEA Comments investment picks
2015/1/16
By Georgi Kantchev LONDON--Oil futures rallied on Friday after the International Energy Agency said a price recovery might be in sight.
Sign-up for Oil Edges Higher on IEA Comments -- 2nd Update investment picks
2015/1/16
By Georgi Kantchev LONDON----Oil futures rallied on Friday after the International Energy Agency said a price recovery might be in sight.
Sign-up for Oil Edges Higher on IEA Comments -- Update investment picks
2015/1/16
By Peter Evans and Selina Williams But will be a boon for some sectors LONDON --
Sign-up for Oil slide to erode European energy companies' earnings investment picks
2015/1/16
Oil futures took a breather from a selloff in Asian trade Friday as investors sought for signs of tighter supply that could stem further declines in oil prices.
Sign-up for Oil Stable in Asian Trade but Speedy Rebound Unlikely investment picks
Oiltanking Partners, L.P. (NYSE: OILT) (the “Partnership”) announced today that the board of directors of its general partner declared an increase in the quarterly cash distribution to $0.285 per unit, or $1.14 per unit on an annualized basis, for the fourth quarter of 2014.
Sign-up for Oiltanking Partners Declares Increase in Quarterly Distribution investment picks
AFFINITY Trial to Continue as Planned Following Completion of Interim Futility Analysis BOTHELL, Wash.
Sign-up for OncoGenex Announces Update on Phase 3 AFFINITY Trial Evaluating Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer investment picks
OncoGenex Announces Update on Phase 3 AFFINITY Trial Evaluating Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer Canada NewsWire AFFINITY Trial to Continue as Planned Following Completion of Interim Futility Analysis BOTHELL, Wash.
Sign-up for OncoGenex Announces Update on Phase 3 AFFINITY Trial Evaluating Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer investment picks
Median Overall Survival of 14.6 Months in Tumor Notch3 High Patients and 11.6 Months in All Patients REDWOOD CITY, Calif., Jan.
Sign-up for OncoMed Presents Final Phase 1b Safety, Efficacy and Biomarker Data for Tarextumab in Pancreatic Cancer at the 2015 Gastrointestinal Cancer Symposium investment picks
OpenText Buys Actuate Corporation Actuate Adds Powerful Analytics to OpenText Canada NewsWire WATERLOO, Ontario , Jan.
Sign-up for OpenText Buys Actuate Corporation investment picks
Actuate Adds Powerful Analytics to OpenText WATERLOO, Ontario , Jan.
Sign-up for OpenText Buys Actuate Corporation investment picks
2015/1/16
ROANOKE, Va.
Sign-up for Optical Cable Corporation Declares Quarterly Dividend investment picks
Celgene International Sàrl (NASDAQ: CELG), a wholly-owned subsidiary of Celgene Corporation, today announced that the European Commission (EC) has granted marketing authorisation for OTEZLA ® (apremilast), the company’s oral selective inhibitor of phosphodiesterase 4 (PDE4), in two therapeutic indications: 1 “The approval of OTEZLA ® is an important new option for the treatment of patients who are not experiencing adequate relief for their conditions.
Sign-up for Oral OTEZLA® (apremilast) Approved by the European Commission for the Treatment of both Patients with Psoriasis and Psoriatic Arthritis investment picks
JERUSALEM , January 16, 2015 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) ( http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Israel Patent Office has granted the Company's patent for its invention, titled "Methods and Compositions for Oral Administrations of Exenatide." About ORMD-0901 - Oral GLP-1 Glucagon-like peptide-1 (GLP-1) is an incretin hormone that stimulates the secretion of insulin from the pancreas.
Sign-up for Oramed Granted Patent in Israel for Oral Administration of GLP-1 investment picks
TSX:ORV Production of 22,195 ounces of gold and 7.0 million pounds of copper, an increase of 18% and 48%, respectively, compared with the first quarter of fiscal 2014 Gold equivalent production of approximately 41,545 ounces Cash of $18.1 million and total debt of $ 3.5 million as at December 31, 2014 TORONTO , Jan.
Sign-up for Orvana Continues to Deliver Results in the First Quarter 2015 and Reaffirms 2015 Production Guidance investment picks
Orvana Continues to Deliver Results in the First Quarter 2015 and Reaffirms 2015 Production Guidance Canada NewsWire TSX:ORV Production of 22,195 ounces of gold and 7.0 million pounds of copper, an increase of 18% and 48%, respectively, compared with the first quarter of fiscal 2014 Gold equivalent production of approximately 41,545 ounces Cash of $18.1 million and total debt of $ 3.5 million as at December 31, 2014 TORONTO , Jan.
Sign-up for Orvana Continues to Deliver Results in the First Quarter 2015 and Reaffirms 2015 Production Guidance investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Neurocrine Biosciences Announces Granting of Orphan Drug Status for NBI-77860 in Congenital Adrenal Hyperplasia to Orvana Continues to Deliver Results in the First Quarter 2015 and Reaffirms 2015 Production Guidance
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent